Cargando…
The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1
BACKGROUND: Severe COVID‐19 disease is associated with thrombotic complications and extensive fibrin deposition. This study investigates whether the hemostatic complications in COVID‐19 disease arise due to dysregulation of the fibrinolytic system. METHODS: This prospective study analyzed fibrinolyt...
Autores principales: | Whyte, Claire S., Simpson, Megan, Morrow, Gael B., Wallace, Carol A., Mentzer, Alexander J., Knight, Julian C., Shapiro, Susan, Curry, Nicola, Bagot, Catherine N., Watson, Henry, Cooper, Jamie G., Mutch, Nicola J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349442/ https://www.ncbi.nlm.nih.gov/pubmed/35780481 http://dx.doi.org/10.1111/jth.15806 |
Ejemplares similares
-
Commentary on “The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1”
por: von Meijenfeldt, Fien A.
Publicado: (2022) -
A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease
por: Morrow, Gael B., et al.
Publicado: (2021) -
Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19
por: Whyte, Claire S., et al.
Publicado: (2020) -
Location, location, location: Fibrin, cells, and fibrinolytic factors in thrombi
por: Narwal, Anuj, et al.
Publicado: (2023) -
Functional plasminogen activator inhibitor 1 is retained on the activated platelet membrane following platelet activation
por: Morrow, Gael B., et al.
Publicado: (2019)